SECRETION OF RADIOACTIVITY IN BREAST-MILK FOLLOWING ADMINISTRATION OF TC-99M-MAG3

被引:1
|
作者
EVANS, JL
MOUNTFORD, PJ
HERRING, AN
RICHARDSON, MA
机构
[1] Department of Nuclear Medicine, Kent and Canterbury Hospital, Canterbury, Kent, CTI 3NG, Ethelbert Road
[2] Department of Nuclear Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham
[3] Department of Imaging, South Cleveland Hospital, Middlesborough, TS4 3BVJ, Marton Road
关键词
D O I
10.1097/00006231-199302000-00006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Measurements were made of the fraction of injected radioactivity which was secreted in breast milk following Tc-99(m)-MAG3 dynamic renal scans of two nursing mothers. The activity concentration in the milk expressed at different times after injection was found to decrease monoexponentially, with effective half-lives of 3.2 and 4.0 h. Two models were applied to each set of data and predicted an overall mean infant effective dose equivalent per unit administered activity of 2.9 muSv MBq-1 and a maximum of 4.5 muSv MBq-1. The results demonstrated that it was not essential to interrupt breast feeding following administration of 100 MBq Tc-99(m)-MAG3 for a dynamic renal scan. If a renal perfusion scan is performed using greater activities of Tc-99(m)-MAG3, the mother should interrupt feeding and not resume until measurements on her expressed milk samples indicate that the effective dose equivalent to the infant will be less than 1 mSv. However, it was noted that a considerably lower radiation dose to the infant could be achieved by using Tc-99(m)-DTPA. Therefore, it was concluded that whenever clinically appropriate Tc-99(m)-DTPA should be used for both types of renal investigations of breast-feeding mothers.
引用
收藏
页码:108 / 111
页数:4
相关论文
共 50 条
  • [1] BREAST-MILK RADIOACTIVITY FOLLOWING INJECTION OF TC-99(M)-PERTECHNETATE AND TC-99(M)-GLUCOHEPTONATE
    MOUNTFORD, PJ
    COAKLEY, AJ
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 1987, 8 (10) : 839 - 845
  • [2] PHARMACOKINETICS OF TC-99M-MAG3
    BUBECK, B
    BRANDAU, W
    FREY, M
    BONZEL, K
    EISENHUT, M
    GEORGI, P
    [J]. NUKLEARMEDIZIN, 1988, 27 (02) : 13 - 13
  • [3] EXCRETION OF RADIOACTIVITY IN BREAST-MILK FOLLOWING TC-99M-SN POLYPHOSPHATE
    OCONNELL, MEA
    SUTTON, H
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1976, 49 (580): : 377 - 379
  • [4] EXCRETION OF RADIOACTIVITY IN BREAST-MILK FOLLOWING INJECTION OF TC-99M-DTPA
    MOUNTFORD, PJ
    COAKLEY, AJ
    HALL, FM
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 1985, 6 (06) : 341 - 345
  • [5] POSSIBILITIES AND LIMITATIONS OF TC-99M-MAG3 CLEARANCE
    KESKE, U
    DEBRANDPASSARD, A
    CORDES, M
    WILFLING, M
    LANGER, M
    EICHSTADT, H
    FELIX, R
    [J]. NUKLEARMEDIZINER, 1991, 14 (04): : 207 - 213
  • [6] TC-99M-MAG3 CLEARANCE IN NORMALS AND PATIENTS
    CLAESSENS, RAMJ
    CORSTENS, FHM
    [J]. RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH /, 1988, : 301 - 303
  • [7] SECRETION OF RADIOACTIVITY IN BREAST-MILK FOLLOWING ADMINISTRATION OF I-123 HIPPURAN
    MOUNTFORD, PJ
    COAKLEY, AJ
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1989, 62 (736): : 388 - 389
  • [8] BREAST-MILK RADIOACTIVITY AFTER TC-99M MAA LUNG STUDIES
    CRANAGE, R
    PALMER, M
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1985, 11 (6-7): : 257 - 259
  • [9] TC-99M-MAG3 - A RENAL RADIOPHARMACEUTICAL IN ROUTINE USE
    BRITTON, KE
    ALNAHHAS, AA
    JAFRI, RA
    BOMANJI, J
    SOLANKI, K
    NIMMON, CC
    [J]. RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH /, 1988, : 321 - 322
  • [10] COMPARISON OF TC-99M-DTPA AND TC-99M-MAG3 IN CHILDREN WITH VESICOURETHRAL REFLUX
    POROPAT, M
    BASIC, M
    BATINIC, D
    DODIG, D
    KUSTER, Z
    NIZIC, I
    MILOSEVIC, D
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 296 - 296